A Pilot Trial of Pre-Operative Chemoradiotherapy Using Capecitabine (Xeloda), External Beam Radiation and Cetuximab (Erbitux) Followed by Definitive Surgery in Patients With Localized (Non-Metastatic) Rectal Cancer.

Trial Profile

A Pilot Trial of Pre-Operative Chemoradiotherapy Using Capecitabine (Xeloda), External Beam Radiation and Cetuximab (Erbitux) Followed by Definitive Surgery in Patients With Localized (Non-Metastatic) Rectal Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Mar 2016

At a glance

  • Drugs Capecitabine (Primary) ; Cetuximab (Primary)
  • Indications Colorectal cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Mar 2016 Last checked against ClinicalTrials.gov record.
    • 24 Feb 2016 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 12 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top